共 254 条
[1]
Tancredi M(2015)Excess Mortality among Persons with Type 2 Diabetes N Engl J Med 373 1720-1732
[2]
Rosengren A(2016)Risk of cause-specific death in individuals with diabetes: A competing risks analysis Diabetes Care 39 1987-1995
[3]
Svensson A-M(2021)Ceramides in Metabolism: Key Lipotoxic Players Annu Rev Physiol 83 303-330
[4]
Kosiborod M(2014)Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency J Clin Endocrinol Metab 99 45-52
[5]
Pivodic A(2016)Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort Arterioscler Thromb Vasc Biol 36 2424-2430
[6]
Gudbjörnsdottir S(2019)Plasma Ceramides and Sphingomyelins in Relation to Heart Failure Risk: The Cardiovascular Health Study Circ Hear Fail 12 1-8
[7]
Baena-Díez JM(2020)Development and validation of a ceramide- And phospholipid-based cardiovascular risk estimation score for coronary artery disease patients Eur Heart J 41 371-380
[8]
Peñafiel J(2009)Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance Diabetes 58 337-343
[9]
Subirana I(2015)Serum sphingolipids: Relationships to insulin sensitivity and changes with exercise in humans Am J Physiol - Endocrinol Metab 309 E398-408
[10]
Ramos R(2022)The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes Front Endocrinol (Lausanne) 13 1-10